Zhao S Y, Lu X H, Lyu S G, Shan Y Y, Miao C H
Department of Anesthesiology and Perioperative Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450003, China.
Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Yi Xue Za Zhi. 2023 May 9;103(17):1303-1309. doi: 10.3760/cma.j.cn112137-20221121-02449.
To investigate the effects of remimazolam versus propofol on postoperative recovery quality in elderly patients undergoing thoracoscopic laparoscopic radical esophagectomy. A total of 108 elderly patients undergoing thoracoscopic laparoscopic radical esophagectomy under general anesthesia in the Affiliated Cancer Hospital of Zhengzhou University from May to October 2022 were prospectively included. The participants were divided into two groups by the random number table method: remimazolam group (R group, =54) and propofol group (P group, =54). There were 54 cases in the R group, with 35males and 19 females, and aged (65.4±3.1) years. Meanwhile, there were 54 cases in the P group, with 33males and 21 females, and aged (64.5±3.0) years. Anesthesia was induced as follows: remimazolam 0.2-0.3 mg/kg and remifentanil 0.5-1.0 μg/kg were intravenously injected in R group, while propofol 1-2 mg/kg and remifentanil 0.5-1.0 μg/kg were intravenously injected in P group. Subsequently, anesthesia was maintained as follows: remimazolam 0.4-1.0 mg·kg·h and remifentanil 0.05-0.2 μg·kg·min were intravenously infused in group R, while propofol 4-10 mg·kg·h and remifentanil 0.05-0.2 μg·kg·min were intravenously infused in group P. Bispectral index (BIS) was maintained at 45-60 during operation. The main outcome measures were the 15-item quality of recovery (QoR-15) scores 1 day before surgery, 1 day and 3 days after surgery. Secondary outcome measures included mean arterial pressure (MAP), heart rate and pulse oxygen saturation (SpO) recorded 5 min before anesthesia induction (T), 1 min after induction (T), 1 min after endotracheal intubation (T), immediately after skin incision (T) and tracheal extubation (T). The incidence of bradycardia and hypotension and the frequency of application of vasoactive drugs during anesthesia were recorded. Restlessness score (RS) and Ramsay sedation scale during the awakening period were recorded. Emergence time, tracheal extubation time, duration of postanesthesia care unit (PACU) stay and postoperative length of hospital stay were recorded. The incidence of postoperative pulmonary infection and other complications were also recorded. The QoR-15 scale scores [ (, )] of R group 1 day and 3 days after surgery were 114.0 (109.0, 118.3) and 131.0 (127.8, 133.0), which were higher than those of P group [106.0 (101.0, 112.0) and 127.0 (125.0, 129.3)] (both <0.001). The incidence of bradycardia, hypotension and the frequency of application of vasoactive drugs of R group during anesthesia were 5.6% (3/54), 35.2% (19/54) and 27.8% (15/54), which were lower than those in P group [33.3% (18/54), 63.0% (34/54) and 55.6% (30/54), respectively] (all <0.05). RS score during the awakening period in R group was 0.9±0.5, which was lower than that of P group (1.1±0.6) (=0.046). Emergence time, tracheal extubation time and postoperative length of hospital stay of R group were (15.4±4.9) min, (16.6±4.7) min and (11.6±1.4) d, which were shorter than those of P group [(26.2±6.4) min, (27.8±5.8) min and (12.6±1.3) d] (all <0.05). There were no statistically significant differences in Ramsay scores during the awakening period, duration of PACU stay and the incidence of postoperative complications (all >0.05). Both remimazolam and propofol can achieve satisfactory postoperative recovery quality in elderly patients undergoing thoracoscopic laparoscopic radical esophagectomy. Remimazolam has more stable hemodynamics and lower incidence of adverse reactions.
探讨瑞马唑仑与丙泊酚对老年患者行胸腔镜腹腔镜联合根治性食管癌切除术后恢复质量的影响。前瞻性纳入2022年5月至10月在郑州大学附属肿瘤医院接受全身麻醉下胸腔镜腹腔镜联合根治性食管癌切除术的108例老年患者。采用随机数字表法将参与者分为两组:瑞马唑仑组(R组,n = 54)和丙泊酚组(P组,n = 54)。R组54例,男35例,女19例,年龄(65.4±3.1)岁。同时,P组54例,男33例,女21例,年龄(64.5±3.0)岁。麻醉诱导如下:R组静脉注射瑞马唑仑0.2 - 0.3 mg/kg和瑞芬太尼0.5 - 1.0 μg/kg,而P组静脉注射丙泊酚1 - 2 mg/kg和瑞芬太尼0.5 - 1.0 μg/kg。随后,麻醉维持如下:R组静脉输注瑞马唑仑0.4 - 1.0 mg·kg·h和瑞芬太尼0.05 - 0.2 μg·kg·min,而P组静脉输注丙泊酚4 - 10 mg·kg·h和瑞芬太尼0.05 - 0.2 μg·kg·min。术中维持脑电双频指数(BIS)在45 - 60。主要观察指标为术前1天、术后1天和3天的15项恢复质量(QoR - 15)评分。次要观察指标包括麻醉诱导前5分钟(T₀)、诱导后1分钟(T₁)、气管插管后1分钟(T₂)、皮肤切开即刻(T₃)和气管拔管时(T₄)记录的平均动脉压(MAP)、心率和脉搏血氧饱和度(SpO₂)。记录麻醉期间心动过缓和低血压的发生率以及血管活性药物的应用频率。记录苏醒期躁动评分(RS)和Ramsay镇静评分。记录苏醒时间、气管拔管时间、麻醉后恢复室(PACU)停留时间和术后住院时间。记录术后肺部感染及其他并发症的发生率。R组术后1天和3天的QoR - 15量表评分[(中位数,四分位数间距)]分别为114.0(109.0,118.3)和131.0(127.8,133.0),高于P组[分别为106.0(101.0,112.0)和(127.0,125.0,129.3)](均P < 0.001)。R组麻醉期间心动过缓、低血压的发生率以及血管活性药物应用频率分别为5.6%(3/54)、35.2%(19/54)和27.8%(15/54),低于P组[分别为33.3%(18/54)、63.0%(34/54)和55.6%(30/54)](均P < 0.05)。R组苏醒期RS评分为0.9±0.5,低于P组(1.1±0.6)(P = 0.046)。R组苏醒时间、气管拔管时间和术后住院时间分别为(15.4±4.9)分钟、(16.6±4.7)分钟和(11.6±1.4)天,短于P组[分别为(26.2±6.4)分钟、(27.8±5.8)分钟和(12.6±1.3)天](均P < 0.05)。苏醒期Ramsay评分、PACU停留时间和术后并发症发生率差异均无统计学意义(均P > 0.05)。瑞马唑仑和丙泊酚均可使行胸腔镜腹腔镜联合根治性食管癌切除术的老年患者术后恢复质量达到满意效果。瑞马唑仑血流动力学更稳定,不良反应发生率更低。